Western Blot; Sample: Recombinant IL8, Human.
IL8 / Interleukin 8 Antibody (clone C4)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Immunohistochemistry (general), Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$298.00each
Catalog Number: LS-C663556-100
Catalog Number: LS-C663556
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Interleukin 8 antibody LS-C663556 is an unconjugated mouse monoclonal antibody to human Interleukin 8 (IL8). Validated for WB. Cited in 1 publication.
- Application
- IHC, WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- 3-10C | AMCF-I | B-ENAP | C-X-C motif chemokine 8 | GCP-1 | IL-8 | IL8 | Interleukin-8 | K60 | LECT | GCP1 | LUCT | NAF | NAP1 | Neutrophil-activating factor | Interleukin 8 | Protein 3-10C | MDNCF | TSG-1 | CXCL8 | Emoctakin | LYNAP | MONAP | NAP-1 | SCYB8 | T-cell chemotactic factor
- UniProt Number
- P10145
- NCBI GenBank
- NM_000584 | NP_000575.1
- SwissProt
- P10145
Target
- Target
- Human IL8 / Interleukin 8
- Antigen Species
- Human
- Epitope
- The antibody is a mouse monoclonal antibody raised against IL8.
- Gene Name
- CXCL8
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- C4
- Isotype
- IgG
Immunogen
- Immunogen
- Recombinant IL8 (Ser28-Ser99) expressed in E.coli.
- Immunogen Type
- Recombinant Protein Fragment
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- 0.01 M PBS, pH 7.4, 0.05% ProClin™ 300, 50% Glycerol
- Concentration
- 1 mg/mL
- Volume
- 100 Microliter
- Preservative
- Yes
- Purification Method
- Protein A/G Affinity
Storage & Handling
- Storage Conditions
- Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
- Recommended Storage Buffer
- 0.01 M PBS
Expression and secretion of the pro-inflammatory cytokine IL-8 is increased in colorectal cancer cells following the knockdown of non-erythroid spectrin aII. Anne Ackermann, Barbara Lafferton, Guido Plotz, Stefan Zeuzem, Angela Brieger. International journal of oncology. 2020 June;56:1551-1564. PubMed: 32236629